NCT07263789 Effect of a Food Supplement on Blood Glucose Levels in Patients With Impaired Glucose Values
| NCT ID | NCT07263789 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia |
| Condition | Dysglycemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2025-04-08 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2025-04-08 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective is to evaluate the efficacy of Euglycem® plus recommended standard diet on reducing FPG compared to baseline and to recommended standard diet alone after 3 months
Eligibility Criteria
Inclusion Criteria: * BMI ≤30 kg/m2 * subjects able to understand the informed consent and sign it before enrollment in the study * subjects willing to follow all study requirements and perform all study visits as well as collaborate with the investigator. Exclusion Criteria: * ongoing treatment with drugs that can affect blood glucose * current participation in another investigational drug or investigational device trial or inclusion in another investigational drug or investigational device trial within the previous month
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07263789 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dysglycemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07263789 currently recruiting?
Yes, NCT07263789 is actively recruiting participants. Contact the research team at g.derosa@smatteo.pv.it for enrollment information.
Where is the NCT07263789 trial being conducted?
This trial is being conducted at Pavia, Italy, Pavia, Italy.
Who is sponsoring the NCT07263789 clinical trial?
NCT07263789 is sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia. The trial plans to enroll 108 participants.